Economist: U.S. core PCE will not easily decline
Odaily reports that after the Personal Consumption Expenditures (PCE) index rose by 4.1% year-on-year in May, some economists predicted this might mark the peak of price increases. However, Joseph Brusuelas, Chief Economist at RSM, stated that the 0.3% increase in the core inflation rate and the 3.4% year-on-year rise may have lasting impact. Given the evident internal transmission pressure in the Producer Price Index (PPI) over the past few months, unlike the overall data, these prices are unlikely to drop easily.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

